Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Diyu Hou"'
Autor:
Beiying Zhang, Xiaoling Deng, Ruolan You, Jingru Liu, Diyu Hou, Xiaoting Wang, Shucheng Chen, Dongliang Li, Qiang Fu, Jingdong Zhang, Huifang Huang, Xiaoli Chen
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 47, Iss , Pp 100952- (2024)
Background: In addition to being secreted into the intercellular spaces by exocytosis, insulin-like growth factor binding protein 5 (IGFBP5) may also remain in the cytosol or be transported to the nucleus. Depending on the different cellular context
Externí odkaz:
https://doaj.org/article/2b0de562bae44fc5b22392e35b91cde0
Autor:
Xinai Liao, Ling Chen, Jingru Liu, Haoran Hu, Diyu Hou, Ruolan You, Xiaoting Wang, Huifang Huang
Publikováno v:
Epigenetics, Vol 18, Iss 1 (2023)
Patients with acute myeloid leukaemia (AML) have poor prognoses and low overall survival (OS) rates owing to its heterogeneity and the complexity of its tumour microenvironment (TME). N6-methyladenosine (m6A) modification plays a key role in the init
Externí odkaz:
https://doaj.org/article/a967ed0288bc43ffabc6a510b945bfc5
Autor:
Xiaoting Wang, Bin Wang, Weiwu Zhan, Lixia Kang, Shuxia Zhang, Canwei Chen, Diyu Hou, Ruolan You, Huifang Huang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 117, Iss , Pp - (2019)
Aim: Melatonin shows therapeutic benefits in gastric cancer, but the mechanism underlying its anticancer effects remains elusive. The aim of this study was to determine whether melatonin inhibits lung metastasis in gastric cancer. Main methods: A lun
Externí odkaz:
https://doaj.org/article/87ee799ac4334f7792ccb46ef693c8a3
Autor:
Xinai, Liao, Ling, Chen, Jingru, Liu, Haoran, Hu, Diyu, Hou, Ruolan, You, Xiaoting, Wang, Huifang, Huang
Publikováno v:
Epigenetics.
Patients with acute myeloid leukaemia (AML) have poor prognoses and low overall survival (OS) rates owing to its heterogeneity and the complexity of its tumour microenvironment (TME). N6-methyladenosine (m
Autor:
Xinai Liao, Ling Chen, Jingru Liu, Haoran Hu, Diyu Hou, Ruolan You, Xiaoting Wang, Huifang Huang
Publikováno v:
Epigenetics. 18
Autor:
Xinai Liao, Ling Chen, Jingru Liu, Haoran Hu, Diyu Hou, Ruolan You, Xiaoting Wang, Huifang Huang
Background: Patients with acute myeloid leukemia (AML) have a poor prognosis and low overall survival (OS) rate owing to its heterogeneity and the complexity of its tumor microenvironment (TME). N6-methyladenosine (m6A) modification plays a potential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9b5885e807bcbd0e557a0307b9c8ed2
https://doi.org/10.21203/rs.3.rs-1511744/v1
https://doi.org/10.21203/rs.3.rs-1511744/v1
Autor:
Ruolan You, Diyu Hou, Bin Wang, Jingru Liu, Xiaoting Wang, Qirong Xiao, Zhipeng Pan, Dongliang Li, Xiaoming Feng, Lixia Kang, Ping Chen, Huifang Huang
Publikováno v:
Journal of leukocyte biology. 112(2)
The stromal niche plays a pivotal role in AML chemoresistance and energy metabolism reprogramming is a hallmark of a tumor. 5′-Adenosine monophosphate-activated protein kinase (AMPK) is an important energy sensor suppressing mammalian target of rap
Autor:
Xinai Liao, Ling Chen, Jingru Liu, Haoran Hu, Diyu Hou, Ruolan You, Xiaoting Wang, Huifang Huang
Publikováno v:
Epigenetics; 2023, Vol. 18 Issue 1, p1-20, 20p
Autor:
Canwei Chen, Diyu Hou, Weiwu Zhan, Bin Wang, Jieqiong Xie, Qian Huang, Xiaoting Wang, Ping Chen, Ruolan You, Jingru Liu, Hui-Fang Huang
Publikováno v:
Journal of Cellular Physiology. 234:10602-10614
Acute myeloid leukemia (AML) is the most common type of leukemia in adults. AML cells secrete angiogenic factors to remodel vasculature and acquire chemoresistance; however, antiangiogenic drugs are often ineffective in AML treatment. Cancer cell-der
Autor:
Xiaoting Wang, Diyu Hou, Jingru Liu, Huifang Huang, Xuehao Zhang, Tian-di Qin, Weiwu Zhan, Ping Chen, Ruolan You, Bin Wang
Publikováno v:
Ann Transl Med
Background Bone marrow stromal cells (BMSCs) are known to promote chemoresistance in acute myeloid leukemia (AML) cells. However, the molecular basis for BMSC-associated AML chemoresistance remains largely unexplored. Methods The mitochondrial oxidat